Brazil stands out as one of the three largest global markets for bio-inputs, with a turnover of R$ 7 billion in the 2024/25 harvest.

The bio-inputs sector in Brazil surpassed R$ 7 billion in the last harvest (2024/2025), consolidating the country among the three largest in the world, alongside the United States and China. On a global scale, Brazil accounts for between 15% and 18% of the segment and concentrates about 50% of the transactions in Latin America. This growth occurs in parallel with the rapid transformation of the national industry, which registered growth exceeding 50% in the number of companies between 2022 and 2025, driven both by the entry of new players and the diversification of traditional input companies. The data were presented during the third edition of the Bio-inputs Market Intelligence Workshop, promoted by ANPII Bio (National Association for the Promotion and Innovation of the Biological Industry), last March in Campinas. Established as one of the leading forums for strategic analysis in the sector, the event brought together approximately 200 participants, including executives from over 90 companies, with a program focused on disseminating unprecedented and exclusive data, combined with market analysis, trends, and perspectives for bio-inputs in Brazil and worldwide. The meeting also included the participation of representatives from the public sector, such as the Ministry of Agriculture (MPLSA) and Embrapa, as well as specialists and consultancies, bringing together different links in the production chain to improve data-driven decision-making. “The advancement of bio-inputs in Brazil is increasingly linked to access to qualified data, market intelligence, and integration among the different agents in the chain. Initiatives like this workshop are fundamental to sustaining this growth and consolidating the country as one of the global leaders in the development and adoption of these technologies,” says Larissa Bonotto, head of market intelligence and director of operations at ANPII Bio. Global and Regional Scenario — According to data presented by DunhamTrimmer International Bio Intelligence, the global bio-inputs market was estimated at approximately US$15 billion in 2025, with a projected average annual growth of 10% until 2030, reflecting a phase of accelerated expansion and gradual progress towards maturity. The biocontrol segment remains the main pillar of the sector, concentrating more than 50% of this volume, while biostimulants, which are classified as biofertilizers in Brazilian legislation, represent 28%. Inoculants and microbial growth promoters, by strengthening integrated management strategies, account for 17% of the market share. “The growth observed globally is driven by the demand for more sustainable solutions and the need for greater productive efficiency. At the same time, we see an environment of intensified competition and global expansion of companies in the sector,” explains Ignacio Moyano, Vice President of Business Development for Latin America at DunhamTrimmer International Bio Intelligence. Latin America is consolidating itself as one of the main drivers of this expansion, with projected growth of 14% between 2025 and 2030 and expectations of reaching US$ 6.7 billion in revenue by the end of the period. Within this movement, Brazil occupies a prominent position and is consolidating itself as one of the main global references, both in scale of use and in technological development of biological inputs, concentrating about 50% of the regional movement – driven not only by the size of its agriculture, but also by the rapid adoption in extensive crops and by a favorable regulatory environment. According to the consultancy, this strengthening, both in Brazil and in Latin America, is directly associated with the pressure to reduce residues, the search for greater efficiency in the use of nutrients, and the increasing integration of these products into agronomic management, especially in extensive crops such as soybeans, corn, and wheat. This is in addition to the demand for increasingly strategic tools within production systems, capable of promoting plant nutrition, enhancing pest and disease control, and increasing crop resilience to climate stress. From a technological standpoint, this has fostered the advancement of microbial and biotechnological solutions based on the use of microorganisms. Despite this consistent progress, the main challenge for the industry lies in value capture: in an increasingly competitive environment, companies need to advance in demonstrating agronomic results in the field, strengthen producer confidence, and differentiate themselves through the offering of technical services, data generation, and agronomic support, going beyond the product itself. “We have entered a new phase of development in the sector, where expansion in area and adoption is no longer sufficient to sustain growth. Value capture necessarily involves the ability of companies to deliver agronomic consistency, generate reliable data, and support producers in decision-making, in an increasingly technical and competitive context,” adds Moyano. Mercosur, opportunities and challenges — In this transforming global environment, the international scenario adds new relevant variables, such as the progress of negotiations within Mercosur. The trade opening foreseen in the agreement creates important opportunities, such as the elimination of tariffs in approximately 92% of bilateral trade, greater access to the European market, expansion of agricultural exports, and strengthening of agro-industrial chains. On the other hand, it also increases international competition, puts pressure on margins, raises regulatory and traceability requirements, and intensifies pressure on input prices. In practice, market opening expands growth potential but does not guarantee profitability, reinforcing the need for greater efficiency and competitiveness on the part of companies. Brazilian Market and Projections 2029/2030 — In Brazil, data presented by Blink Inteligência Aplicada, through its founder and CEO, Lars Schobinger, shows that the national market has already exceeded R$ 7 billion in the last harvest, considering commercial products and on-farm production. In this context, soybean, corn, sugarcane, cotton, coffee, and citrus crops concentrate 96% of the biologicals market, highlighting the strong presence of these inputs in large-scale production systems. Furthermore, bio-inputs already represent 7.2% of the market compared to chemicals, with the largest share in corn (10.1%), followed by sugarcane (8.1%), and soybeans (7.1%). Analyzing by segment, bionematicides lead with 31% market share, followed by bioinsecticides (25%) and biofungicides (15%), which have been consistently expanding their market share. Regarding the area treated with commercial biologicals, the survey shows continuous progress. Even so, the value of sales grew at a slower pace than observed in previous harvests: compared to 2023/24, the potential treated area (PAT) increased by 15.8%, but at the same time, the market value grew by 3.6%, with a projected slight reduction in the 25/26 harvest, but still with significant progress in the treated area, highlighting a mismatch between adoption and value capture. “The accelerated entry of new players makes the market more fragmented and competitive, intensifying the price war and compressing margins, even in a scenario of greater consumption and adoption in the field,” says Lars Schobinger, founder and CEO of Blink Inteligência Aplicada. However, in the medium term, the sector is expected to enter a new wave of growth, with a projected expansion of 66% in the area treated with commercial biologicals over the next five years, representing an average annual growth of 10.6% between 2025 and 2030. Brazilian industry in strong expansion — Data from ANPII Bio, presented by 5P2R Marketing de Precisão, reinforces the current expansion of the national industry. The survey, which includes exclusive and unprecedented data from the Brazilian industry, was conducted by the association based on the analysis of 30 companies throughout 2025, through quarterly data collection. The analysis integrates a historical database initiated in 2009, giving the entity the longest statistical series on bio-inputs in the country, with 19 years of continuous data. The study also demonstrates that, between 2022 and 2025, the number of companies grew by more than 50%, reflecting both the emergence of new entrants and the expansion of the portfolio of companies already consolidated in other segments, such as fertilizers and chemical pesticides. Currently, there are more than 200 companies formally registered with MPLSA (Ministry of Agriculture, Livestock and Supply). Furthermore, Brazil already has more than 1,500 registered biological inputs, even before the complete regulation of the Bio-inputs Law. Among the highlights are inoculants, which represent 60% of registrations, followed by biological pesticides (39%) and biofertilizers (2%). The data also demonstrates that the national industry is gaining prominence with low external dependence: Brazilian companies account for 85% of production and 75% of recent volume growth, while only 15% of biological products are imported. Even in the face of challenges such as supply pressure, credit risks, and pressure on distribution channels, companies associated with ANPII Bio project a 17% growth in the consumption of bio-inputs in the country this year. “The scenario combines an increase in the number of companies and products, expansion of industrial capacity, and faster growth in volume than in value, in a more competitive and demanding environment. Even so, the outlook for 2026 remains positive, and the market will continue to strengthen and diversify,” says Anderson Nora Ribeiro, founding partner of 5P2R Marketing de Precisão. According to the spokesperson for ANPII Bio, the data reinforces Brazil's strategic role in the global advancement of bio-inputs. “The country has the productive scale, industrial capacity, and an increasingly structured environment to support the sector's growth. The challenge now is to transform this progress into consistent value for the entire chain, with innovation, quality, and the generation of results in the field,” concludes Larissa Bonotto.

This text was translated by machine from Brazilian Portuguese.